KAZIA THERAPEUTICS LTD's ticker is KZIA and the CUSIP is 48669G105. A total of 11 filers reported holding KAZIA THERAPEUTICS LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $4,000 | -89.2% | 994 | -79.8% | 0.00% | – |
Q1 2022 | $37,000 | -41.3% | 4,911 | -34.6% | 0.00% | – |
Q4 2021 | $63,000 | +43.2% | 7,511 | +63.9% | 0.00% | – |
Q3 2021 | $44,000 | -2.2% | 4,583 | 0.0% | 0.00% | – |
Q2 2021 | $45,000 | +50.0% | 4,583 | +29.1% | 0.00% | – |
Q4 2020 | $30,000 | – | 3,549 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Transform Wealth, LLC | 106,245 | $35,000 | 0.01% |
UBS Group AG | 1,546 | $5,000 | 0.00% |
Renaissance Technologies | 34,325 | $115,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 5 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
BREWIN DOLPHIN LTD | 32 | $107 | 0.00% |
MORGAN STANLEY | 63,017 | $210,000 | 0.00% |
AdvisorNet Financial, Inc | 5 | $0 | 0.00% |